The 2024 Data is Now Available in MedAxcess! 

What's Next: 

  • View your data "live" in MedAxcess or access your Key Indicator Report
  • Haven't submitted yet? It's not too late! We will accept your 2024 data submission at any time throughout the year. Click here for all data submission instructions.

Have questions?  CONTACT US

ABOUT MEDAXCESS

RESOURCES

SUPPORT

ABOUT MEDAXCESS

MedAxcess is the cardiovascular industry's leading data platform and analytics solution, powered by more than 20 years of data and over 800 metrics from key areas such as:

  • Access and patient encounter volumes
  • Care management
  • Financials staffing revenue and expenses
  • Invasive testing and procedures
  • Non-invasive diagnostic imaging
  • Provider compensation and wRVU production

MedAxiom collects data throughout the year from cardiovascular programs across the country, providing the membership community with key insights and trends needed to transform cardiovascular care.

MEDAXCESS SURVEY CYCLE

  1. Submit Data through MedAxcess
  2. Receive a Key Indicator Report with Benchmarking and Trending Data
  3. Attend CV Transforum Spring Conference for in-Depth Analysis of Data
  4. Participate in a Personalized Performance Review with Your MedAxiom Membership Liaison
  5. Use the Cardiovascular Provider Compensation and Production Survey Report to Benchmark and Negotiate

Custom Annual Key Indicator Reports

Help your practice:

  • Benchmark performance against other programs
  • Understand current trends for predicting future performance
  • Evaluate efficiencies and identify improvement opportunities
  • Set goals for the upcoming year

View a sample Key Indicator Report by Patient Panel Per 1,000 Active Patients

View a sample Key Indicator Report by Program Designated Physician FTE

RESOURCES

                                                              

 

SUPPORT

 
Join the MedAxiom community to gain access and help advance cardiovascular care.

 

Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.